Correction to GPR52 Antagonist Reduces Huntingtin Levels and Ameliorates Huntington's Disease-Related Phenotypes

J Med Chem. 2021 Jan 28;64(2):1220-1221. doi: 10.1021/acs.jmedchem.0c01981. Epub 2020 Dec 8.
No abstract available

Publication types

  • Published Erratum